Speaker Bio
Marc is co-founder and CEO of Minoryx, a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical need which has raised more than €120 million since its inception.
Marc is co-founder and CEO of Minoryx, a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical need which has raised more than €120 million since its inception.